0001654954-20-011150.txt : 20201014 0001654954-20-011150.hdr.sgml : 20201014 20201014155706 ACCESSION NUMBER: 0001654954-20-011150 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20201013 FILED AS OF DATE: 20201014 DATE AS OF CHANGE: 20201014 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: OAKES FRANK R. CENTRAL INDEX KEY: 0001620188 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37619 FILM NUMBER: 201239056 MAIL ADDRESS: STREET 1: C/O STELLAR BIOTECHNOLOGIES, INC. STREET 2: 332 EAST SCOTT STREET CITY: PORT HUENEME STATE: CA ZIP: 93041 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Edesa Biotech, Inc. CENTRAL INDEX KEY: 0001540159 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 BUSINESS PHONE: (905) 475-1234 MAIL ADDRESS: STREET 1: 100 SPY COURT CITY: MARKHAM STATE: A6 ZIP: L3R 5H6 FORMER COMPANY: FORMER CONFORMED NAME: Stellar Biotechnologies, Inc. DATE OF NAME CHANGE: 20120120 4 1 section16.xml PRIMARY DOCUMENT X0306 4 2020-10-13 0001540159 Edesa Biotech, Inc. EDSA 0001620188 OAKES FRANK R. C/O EDESA BIOTECH, INC. 100 SPY COURT MARKHAM A6 L3R 5H6 ONTARIO, CANADA true Stock option (right to buy) 7.44 2020-10-13 4 A false 20000 0 A 2030-10-13 Common shares 20000 20000 D This option vests monthly in equal proportions over 36 months beginning on the Grant Date. /s/ Frank R. Oakes 2020-10-14